secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001104659-25-052452
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics raises $13M in public offering of common stock and warrants
--------------------------------------------------------------------------------

- Offering of 9,285,714 shares and warrants to purchase 18,571,428 shares at combined price $1.40 per unit.
- Gross proceeds of ~$13M; closing expected May 27, 2025.
- Warrants exercisable immediately at $1.40/share, expire in 5 years, with beneficial ownership cap.
- GMS Ventures (affiliated with directors) committed $6M of the offering.
- Underwriting agreement entered with BTIG, LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465925052452/0001104659-25-052452-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465925052452/tm2516054d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-052452

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer